Proffered Paper - Breast cancer, metastatic 2
Invited Discussant 274O, 275O and 276O
Date
21 Sep 2020Session
Proffered Paper - Breast cancer, metastatic 2Presenters
Lesley FallowfieldAuthors
L. FallowfieldAuthor affiliations
- Sussex Health Outcomes Research & Education In Cancer, Brighton and Sussex Medical School, University of Sussex, BN1 9PX - Brighton/GB
Resources
Resources from the same session
274O - Health-related quality of life (HRQoL) changes with veliparib in patients (pts) with metastatic or locally advanced breast cancer in the phase III BROCADE 3 study
Presenter: Michael Friedlander
Session: Proffered Paper - Breast cancer, metastatic 2
Resources:
Abstract
Slides
Webcast
275O - Impact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+ metastatic breast cancer (MBC) with and without brain metastases (BM)
Presenter: Volkmar Mueller
Session: Proffered Paper - Breast cancer, metastatic 2
Resources:
Abstract
Slides
Webcast
276O - Pooled analysis of patient (pt)-reported quality of life (QOL) in the MONALEESA (ML)-2, -3, and -7 trials of ribociclib (RIB) plus endocrine therapy (ET) to treat hormone receptor–positive, HER2-negative (HR+/HER2−) advanced breast cancer (ABC)
Presenter: Peter A. Fasching
Session: Proffered Paper - Breast cancer, metastatic 2
Resources:
Abstract
Slides
Webcast
LBA19 - GEICAM/2014-12 (FLIPPER) study: First analysis from a randomized phase II trial of fulvestrant (F)/palbociclib (P) versus (vs) F/placebo (PL) as first-line therapy in postmenopausal women with HR (hormone receptor)+/HER2– endocrine sensitive advanced breast cancer (ABC)
Presenter: Joan Albanell
Session: Proffered Paper - Breast cancer, metastatic 2
Resources:
Abstract
Slides
Webcast
Q&A and live discussion
Presenter: Lesley Fallowfield
Session: Proffered Paper - Breast cancer, metastatic 2
Resources:
Webcast
Invited Discussant LBA19
Presenter: Joseph Gligorov
Session: Proffered Paper - Breast cancer, metastatic 2
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Lesley Fallowfield
Session: Proffered Paper - Breast cancer, metastatic 2
Resources:
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.